Litcius/Paper detail

Bifunctional Inhibitors of Influenza Virus Neuraminidase: Molecular Design of a Sulfonamide Linker

Sergei Evteev, D. K. Nilov, Aleksandra M. Polenova, Vytas K. Švedas

2021International Journal of Molecular Sciences13 citationsDOIOpen Access PDF

Abstract

The growing resistance of the influenza virus to widely used competitive neuraminidase inhibitors occupying the active site of the enzyme requires the development of bifunctional compounds that can simultaneously interact with other regulatory sites on the protein surface. When developing such an inhibitor and combining structural fragments that could be located in the sialic acid cavity of the active site and the adjacent 430-cavity, it is necessary to select a suitable linker not only for connecting the fragments, but also to ensure effective interactions with the unique arginine triad Arg118-Arg292-Arg371 of neuraminidase. Using molecular modeling, we have demonstrated the usefulness of the sulfonamide group in the linker design and the potential advantage of this functional group over other isosteric analogues.

Topics & Concepts

NeuraminidaseLinkerBifunctionalSulfonamideActive siteSialic acidChemistryBiochemistryInfluenza A virusEnzymeNeuraminidase inhibitorBinding siteArginineVirusCombinatorial chemistryStereochemistryBiologyVirologyAmino acidMedicineCoronavirus disease 2019 (COVID-19)Computer scienceDiseasePathologyCatalysisInfectious disease (medical specialty)Operating systemInfluenza Virus Research StudiesCarbohydrate Chemistry and SynthesisGlycosylation and Glycoproteins Research
Bifunctional Inhibitors of Influenza Virus Neuraminidase: Molecular Design of a Sulfonamide Linker | Litcius